The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Armando Arredondo

National Institute of Public Health





Name/email consistency: high



  • National Institute of Public Health, Cuernavaca, Morelos, Mexico. 2004 - 2010
  • Centro de Investigación en Sistemas de Salud, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. 2006 - 2008
  • Health Services Unit, Research Center on Health Systems, Cuernavaca, Mexico. 2007
  • Research Center on Health Systems, National Institute of Public Health, Av. Universidad 655, Col. Sta. Maria Ahuacatitlán, Mexico. 2005
  • Centre for Health Systems Research, National Institute of Public Health, Mexico. 2005


  1. Hospitalization costs associated with hypertension as a secondary diagnosis. Arredondo, A. Am. J. Hypertens. (2010) [Pubmed]
  2. Equity, governance and financing after health care reform: lessons from Mexico. Arredondo, A., Orozco, E. Int. J. Health. Plann. Manage (2008) [Pubmed]
  3. Out-of-pocket costs to users: medicine options for hypertension. Arredondo, A. Am. J. Hypertens. (2008) [Pubmed]
  4. Equity and accessibility in health? Out-of-pocket expenditures on health care in middle income countries: evidence from Mexico. Arredondo, A., Nájera, P. Cad. Saude. Publica (2008) [Pubmed]
  5. Economic burden of expected epidemiological changes in diseases related to tobacco, Mexico. Arredondo, A., Carrillo, C., Zuñiga, A. Rev. Saude. Publica (2007) [Pubmed]
  6. Effects of health decentralization, financing and governance in Mexico. Arredondo, A., Orozco, E. Rev. Saude. Publica (2006) [Pubmed]
  7. Who pays more for health services in middle-income countries: lessons from Mexico. Arredondo, A., Nájera, P. Public. Health (2005) [Pubmed]
  8. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico. Arredondo, A., Zúñiga, A., Parada, I. Public. Health (2005) [Pubmed]
  9. Evidences on weaknesses and strengths from health financing after decentralization: lessons from Latin American countries. Arredondo, A., Orozco, E., De Icaza, E. Int. J. Health. Plann. Manage (2005) [Pubmed]
  10. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Arredondo, A., Burke, T.A., Carides, G.W., Lemus, E., Querol, J. Rev. Invest. Clin. (2005) [Pubmed]
  11. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. Arredondo, A., Zúñiga, A. Diabetes. Care (2004) [Pubmed]
WikiGenes - Universities